Forte Biosciences (FBRX) Misses Q3 EPS by 2c
Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Forte Biosciences (NASDAQ: FBRX) reported Q3 EPS of ($0.18), $0.02 worse than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.